Physicians' Academy for Cardiovascular Education

The advent of novel nonsteroidal mineralocorticoid receptor antagonists in heart failure

3' education - Nov. 10, 2015 - AHA 2015, Orlando, FL, USA - Prof Bertram Pitt

Video navigation menu

  • Mineralocorticoid receptor antagonists (MRAs) in heart failure 0:00
  • Development of new non-steroidal MRAs 1:09
  • ODD-trial: comparing finerenone with spironolactone in HF and renal disease 1:41
  • ODD-HF trial: comparing finerenone with eplenerone 2:17
  • Ongoing and upcoming studies evaluating finerenone in patients with diabetic nephropathy 2:58

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: